BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19959276)

  • 1. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
    Zigeuner R; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Weizer A; Kikuchi E; Remzi M; Raman JD; Bolenz C; Bensalah K; Capitanio U; Koppie TM; Kassouf W; Sircar K; Patard JJ; Fernández MI; Wood CG; Montorsi F; Ströbel P; Wheat JC; Haitel A; Oya M; Guo CC; Ng C; Chade DC; Sagalowsky A; Langner C
    Eur Urol; 2010 Apr; 57(4):575-81. PubMed ID: 19959276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostication of upper tract urothelial carcinoma: what do we really need?
    Dalbagni G
    Eur Urol; 2010 Apr; 57(4):582-3; discussion 583-5. PubMed ID: 20004054
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
    Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
    Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
    Raman JD; Ng CK; Scherr DS; Margulis V; Lotan Y; Bensalah K; Patard JJ; Kikuchi E; Montorsi F; Zigeuner R; Weizer A; Bolenz C; Koppie TM; Isbarn H; Jeldres C; Kabbani W; Remzi M; Waldert M; Wood CG; Roscigno M; Oya M; Langner C; Wolf JS; Ströbel P; Fernández M; Karakiewcz P; Shariat SF
    Eur Urol; 2010 Jun; 57(6):1072-9. PubMed ID: 19619934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
    Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
    Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma.
    Li WM; Shen JT; Li CC; Ke HL; Wei YC; Wu WJ; Chou YH; Huang CH
    Eur Urol; 2010 Jun; 57(6):963-9. PubMed ID: 20079965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
    Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
    Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival.
    Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2010 Oct; 17(10):848-54. PubMed ID: 20812922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
    Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
    Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Patel HR
    Eur Urol; 2009 Jun; 55(6):1407. PubMed ID: 19299074
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
    Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.